SOURCE Telik, Inc.
TheStreet highlights 3 stocks that pushed the Drugs industry
Telik (TELK) soared Tuesday after Monday's announcement that the oncology drug development company had entered into a definitive merger agreement with privately held MabVax Therapeutics.
Telik never recovered from hiding the premature deaths of ovarian cancer patients treated with its experimental drug Telcyta in 2007
Carl Icahn's days as an influential activist investor are over after his shameful performance on Yahoo!'s board.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.